网站首页期刊介绍通知公告编 委 会投稿须知电子期刊广告合作联系我们
最新消息:
肝动脉化疗栓塞联合经皮微波凝固疗法治疗中晚期肝癌的临床观察
作者:邱少敏 陈刚 李宏波  
单位:南京市第二医院
关键词:肝动脉化疗栓塞 经皮微波凝固疗法 肝细胞性肝癌 
分类号:
出版年·卷·期(页码):2011·39·第五期(526-529)
摘要:

[摘要] 目的 对比肝动脉化疗栓塞 (TACE) 联合微波凝固疗法(PMCT)治疗中晚期肝癌与单纯TACE治疗的疗效差异。方法 将60例肝癌患者随机分为两组,治疗组(34例)予经导管肝动脉化学栓塞(TACE)联合微波凝固疗法(PMCT)治疗,对照组(26例)单用TACE治疗,术后随访36月,分析两组之间治疗效果、生存率与术后不良反应的差异。结果 治疗组PR 9例,SD 16例,PD 9例,对照组PR4例,SD 13例,PD 9例;治疗组与对照组1年生存率比较显示有显著性差异(P<0.01);两组术后不良反应无统计学差异。结论 TACE联合PMCT治疗中晚期肝癌能提高肝癌患者治疗疗效并且提高晚期生存率。

[Abstract] Objective To contrast the curative effect of the union treatment of TACE and PMCT with the simple treatment of TACE in the treatment of HCC. Methods Sixty patients with HCC were randomly divided into two groups.Treatment group included 34 patients,who were treated with TACE+ PMCT, while control group included 26 patients, who were treated with TACE alone.Sixty patients were followed up 36 months to analyze the difference of therapeutic efficacy,survival rate and adverse reaction between two sets. Results In treatment group(34 patients) PR has 9 cases,SD has 16 cases,PD has 9 cases,while in control group (26 patients) PR has 4 cases,SD has 13 cases,PD has 9 cases. It has statistical difference for comparing one year survival rate between treatment group and control group (P<0.01). It has no statistical difference for comparing adverse reaction among the two groups. Conclusions PMCT Combined with TACE can enhance the curative effect on hepatocellular carcinoma and help increase the patients’ survival rate,which is a valuable remedy for HCC to prolong long-term survival rate.

参考文献:
服务与反馈:
文章下载】【发表评论】【查看评论】【加入收藏
提示:您还未登录,请登录!点此登录
您是第 752230 位访问者


 ©《现代医学》编辑部
联系电话:025-83272481;83272479
电子邮件: xdyx@pub.seu.edu.cn

苏ICP备09058541